Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceutical's Sales Slump 18% - WSJ
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?